Published in Clin Microbiol Rev on July 01, 2013
Halitosis: a new definition and classification. Br Dent J (2014) 1.89
Coagulase-negative staphylococci. Clin Microbiol Rev (2014) 1.85
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. Metabolites (2015) 0.87
A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin Infect Dis (2014) 0.80
Real-Time Detection of a Virus Using Detection Dogs. Front Vet Sci (2016) 0.79
Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study. PLoS One (2016) 0.78
A rapid method for breath analysis in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (2014) 0.77
Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. World J Gastroenterol (2016) 0.76
Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer. J Thorac Dis (2016) 0.75
The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. J Breath Res (2016) 0.75
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med (2005) 11.34
Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med (2003) 9.78
Tuberculosis. Lancet (2011) 8.07
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect (2000) 7.50
Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Electronic nose: current status and future trends. Chem Rev (2008) 4.97
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet (2010) 4.71
Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16
Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A (1971) 3.14
Bacterial volatiles: the smell of small organisms. Nat Prod Rep (2007) 2.66
Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta (2004) 2.12
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Aliment Pharmacol Ther (2004) 2.08
Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol (2011) 2.06
Volatile markers of breast cancer in the breath. Breast J (2003) 1.82
Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa. J Clin Microbiol (1979) 1.77
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J (2007) 1.77
Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel) (2011) 1.66
Use of an electronic nose system for diagnoses of urinary tract infections. Biosens Bioelectron (2002) 1.63
Electronic noses and disease diagnostics. Nat Rev Microbiol (2004) 1.61
Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) (2006) 1.57
Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr (2007) 1.56
Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev (2012) 1.54
The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med (1994) 1.48
African pouched rats for the detection of pulmonary tuberculosis in sputum samples. Int J Tuberc Lung Dis (2009) 1.40
Computational parallels between the biological olfactory pathway and its analogue 'the electronic nose': Part II. Sensor-based machine olfaction. Biosystems (1997) 1.40
GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.40
Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J Chromatogr A (2005) 1.39
The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem (2011) 1.36
Volatile organic compounds and microorganisms. CRC Crit Rev Microbiol (1976) 1.32
Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) (2010) 1.31
Exhaled biomarkers in lung cancer. Eur Respir J (2009) 1.31
The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci (Lond) (2006) 1.31
Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A (2007) 1.28
The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27
Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta (2004) 1.25
Method for the collection and assay of volatile organic compounds in breath. Anal Biochem (1997) 1.24
Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol (2006) 1.20
[The formation of ortho-aminoacetophenone by apyocyaninogenic strains of P. aeruginosa]. Zentralbl Bakteriol Orig (1967) 1.20
Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol (2008) 1.19
Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res (2008) 1.18
Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. J Clin Microbiol (1980) 1.17
The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res (2012) 1.17
Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem (2006) 1.17
Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res (2010) 1.16
Aroma-Producing Microörganisms. J Bacteriol (1923) 1.14
Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol (2005) 1.14
Breath ethanol and acetone as indicators of serum glucose levels: an initial report. Diabetes Technol Ther (2005) 1.13
Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol (2009) 1.13
Diagnosis of bacteriuria by detection of volatile organic compounds in urine using an automated headspace analyzer with multiple conducting polymer sensors. J Clin Microbiol (2001) 1.13
Detection of Mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system. Biosens Bioelectron (2004) 1.13
Measurement of volatile organic compounds in exhaled breath as collected in evacuated electropolished canisters. J Chromatogr B Biomed Appl (1995) 1.13
Sniffing out the truth: clinical diagnosis using the electronic nose. Clin Chem Lab Med (2000) 1.13
Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition. Anal Chem (2005) 1.12
Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. J Gastrointestin Liver Dis (2009) 1.10
Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res (2009) 1.09
The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.08
Head-space gas-liquid chromatography for the rapid laboratory diagnosis of urinary tract infections caused by enterobacteria. J Chromatogr (1983) 1.07
Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med Mycol (2009) 1.06
On-line breath analysis with PTR-TOF. J Breath Res (2009) 1.06
Breath tests in medicine. Sci Am (1992) 1.06
Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol (2008) 1.06
2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med (2010) 1.05
The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol Meas (2006) 1.04
Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope (2004) 1.04
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
Assessment of technique for rapid detection of Escherichia coli and Proteus species in urine by head-space gas-liquid chromatography. J Clin Microbiol (1977) 1.01
Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.99
The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. Analyst (2007) 0.99
Screening for bacterial vaginosis: a novel application of artificial nose technology. J Clin Pathol (1997) 0.98
Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria. Appl Microbiol Biotechnol (2012) 0.98
A novel method for rapidly diagnosing the causes of diarrhoea. Gut (2004) 0.97
Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal Chem (2011) 0.97
A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis. Trans R Soc Trop Med Hyg (2009) 0.97
The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol (2004) 0.97
Solid-phase microextraction for the analysis of human breath. Anal Chem (1997) 0.96
Monitoring wound healing by odour. J Wound Care (1997) 0.96
Leg ulcer odour detection identifies beta-haemolytic streptococcal infection. J Wound Care (1995) 0.95
Use of an electronic nose to diagnose Mycobacterium bovis infection in badgers and cattle. J Clin Microbiol (2005) 0.95
Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology (2005) 0.94
Breath analysis and monitoring by membrane extraction with sorbent interface. Anal Chem (2002) 0.94
Background levels of hydrogen cyanide in human breath measured by infrared cavity ring down spectroscopy. Biomarkers (2009) 0.94
Clinical application of breath biomarkers of oxidative stress status. Free Radic Biol Med (1999) 0.93
Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) (2012) 0.92
Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.92
Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom Rev (2010) 0.92
Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med (2000) 0.92
Correlation of pneumonia score with electronic nose signature: A prospective study. Ann Otol Rhinol Laryngol (2005) 0.91
Diagnosis of bacteria in vitro by mass spectrometric fingerprinting:a pilot study. Curr Microbiol (2005) 0.91
Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.90
Breath analysis as a potential diagnostic tool for tuberculosis. Int J Tuberc Lung Dis (2012) 0.90
Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol (2010) 0.90
Device-independent, real-time identification of bacterial pathogens with a metal oxide-based olfactory sensor. Eur J Clin Microbiol Infect Dis (2009) 0.89
Novel noninvasive identification of biomarkers by analytical profiling of chronic wounds using volatile organic compounds. Wound Repair Regen (2010) 0.89
Identifying bacteria in human urine: current practice and the potential for rapid, near-patient diagnosis by sensing volatile organic compounds. Clin Chem Lab Med (2001) 0.89
Volatile products from acetylcholine as markers in the rapid urine test using head-space gas-liquid chromatography. J Chromatogr (1984) 0.87
Evaluation of a novel diagnostic test for bacterial vaginosis: 'the electronic nose'. Int J STD AIDS (2003) 0.86
Head-space gas liquid chromatography for rapid detection of Escherichia coli and Proteus mirabilis in urine. J Clin Pathol (1978) 0.86
Background levels and diurnal variations of hydrogen cyanide in breath and emitted from skin. J Breath Res (2011) 0.85
Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis. Lett Appl Microbiol (2011) 0.83
Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat Cell Biol (2009) 3.05
Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol (2002) 2.54
Rapid identification and typing of listeria species by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2008) 2.46
Intracellular gene expression profile of Listeria monocytogenes. Infect Immun (2006) 2.45
Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol (2005) 2.37
Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol (2009) 2.28
Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell (2002) 2.23
CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity (2006) 2.06
GenomeViz: visualizing microbial genomes. BMC Bioinformatics (2004) 1.97
The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation--potential role for a reduction in reactive oxygen species generation. Crit Care Med (2010) 1.78
Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora. J Bacteriol (2005) 1.77
Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J Clin Microbiol (2003) 1.71
Comparative microbial genome visualization using GenomeViz. Methods Mol Biol (2007) 1.69
The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol (2006) 1.68
Galleria mellonella as a model system for studying Listeria pathogenesis. Appl Environ Microbiol (2009) 1.63
Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest (2006) 1.58
Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1. Int J Med Microbiol (2007) 1.56
A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. Am J Respir Crit Care Med (2014) 1.55
Temporal transcriptomic analysis of the Listeria monocytogenes EGD-e sigmaB regulon. BMC Microbiol (2008) 1.54
Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J Immunol (2006) 1.53
Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit Care Med (2008) 1.53
IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol (2008) 1.52
Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC Res Notes (2009) 1.49
Whole-genome sequence of Listeria welshimeri reveals common steps in genome reduction with Listeria innocua as compared to Listeria monocytogenes. J Bacteriol (2006) 1.48
The intracellular sRNA transcriptome of Listeria monocytogenes during growth in macrophages. Nucleic Acids Res (2011) 1.47
Reassessment of the Listeria monocytogenes pan-genome reveals dynamic integration hotspots and mobile genetic elements as major components of the accessory genome. BMC Genomics (2013) 1.43
Pathogenomics of Listeria spp. Int J Med Microbiol (2007) 1.39
Identification of sigma factor sigma B-controlled genes and their impact on acid stress, high hydrostatic pressure, and freeze survival in Listeria monocytogenes EGD-e. Appl Environ Microbiol (2004) 1.32
Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol (2003) 1.32
Lipoproteins of Listeria monocytogenes are critical for virulence and TLR2-mediated immune activation. J Immunol (2008) 1.31
Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity. MBio (2014) 1.29
Comparative analysis of plasmids in the genus Listeria. PLoS One (2010) 1.22
The heat-shock response of Listeria monocytogenes comprises genes involved in heat shock, cell division, cell wall synthesis, and the SOS response. Microbiology (2007) 1.19
The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization. Cell Microbiol (2005) 1.18
Listeriolysin of Listeria monocytogenes forms Ca2+-permeable pores leading to intracellular Ca2+ oscillations. Cell Microbiol (2002) 1.17
Listeria as an enteroinvasive gastrointestinal pathogen. Curr Top Microbiol Immunol (2009) 1.17
Comparative genomics and transcriptomics of lineages I, II, and III strains of Listeria monocytogenes. BMC Genomics (2012) 1.16
Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc Natl Acad Sci U S A (2012) 1.14
RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J (2012) 1.14
Identification and characterization of a peptidoglycan hydrolase, MurA, of Listeria monocytogenes, a muramidase needed for cell separation. J Bacteriol (2003) 1.13
Outbreak of a novel Enterobacter sp. carrying blaCTX-M-15 in a neonatal unit of a tertiary care hospital in Tanzania. Int J Antimicrob Agents (2011) 1.12
Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett (2004) 1.11
Activation of the unfolded protein response by Listeria monocytogenes. Cell Microbiol (2012) 1.09
Comparative and functional genomics of Listeria spp. J Biotechnol (2006) 1.08
Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC Infect Dis (2013) 1.06
Autophagy targeting of Listeria monocytogenes and the bacterial countermeasure. Autophagy (2011) 1.04
The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. Vascul Pharmacol (2010) 1.04
A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion. J Cell Sci (2008) 1.03
Simultaneous deficiency of both MurA and p60 proteins generates a rough phenotype in Listeria monocytogenes. J Bacteriol (2005) 1.02
Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics (2005) 1.01
Lung cancer biomarkers: State of the art. J Carcinog (2013) 1.00
Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC Infect Dis (2009) 1.00
Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am J Respir Cell Mol Biol (2012) 0.99
The Dual Role of TNF in Pulmonary Edema. J Cardiovasc Dis Res (2010) 0.99
Complete Genome Sequence of the Probiotic Enterococcus faecalis Symbioflor 1 Clone DSM 16431. Genome Announc (2013) 0.99
Human infective endocarditis caused by Streptococcus suis serotype 2. J Clin Microbiol (2005) 0.99
Sterol and pH interdependence in the binding, oligomerization, and pore formation of Listeriolysin O. Biochemistry (2007) 0.98
Complete genome sequence of Listeria seeligeri, a nonpathogenic member of the genus Listeria. J Bacteriol (2010) 0.96
Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification. J Immunol (2005) 0.95
Host gene expression profiling in pathogen-host interactions. Curr Opin Immunol (2006) 0.95
Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J Cell Physiol (2010) 0.94
Aerolysin from Aeromonas hydrophila perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/B6 cells. J Infect Dis (2011) 0.93
microRNA response to Listeria monocytogenes infection in epithelial cells. Int J Mol Sci (2012) 0.93
Complete Genome Sequence of Phage-Like Plasmid pECOH89, Encoding CTX-M-15. Genome Announc (2014) 0.93
In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. J Androl (2007) 0.93
Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes. Vaccine (2003) 0.93
Uropathogenic Escherichia coli block MyD88-dependent and activate MyD88-independent signaling pathways in rat testicular cells. J Immunol (2008) 0.92
Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC Microbiol (2014) 0.92
Comparative genome-wide analysis of small RNAs of major Gram-positive pathogens: from identification to application. Microb Biotechnol (2010) 0.91
Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms. J Immunol (2008) 0.90
Complete sequences of plasmids from the hemolytic-uremic syndrome-associated Escherichia coli strain HUSEC41. J Bacteriol (2012) 0.90
Brain infection and activation of neuronal repair mechanisms by the human pathogen Listeria monocytogenes in the lepidopteran model host Galleria mellonella. Virulence (2013) 0.89
B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology (2011) 0.88
Invasiveness is a variable and heterogeneous phenotype in Listeria monocytogenes serotype strains. Int J Med Microbiol (2006) 0.88
Surfactant proteins SP-A and SP-D in human health and disease. Arch Immunol Ther Exp (Warsz) (2005) 0.88
Functional transfer of eukaryotic expression plasmids to mammalian cells by Listeria monocytogenes: a mechanistic approach. J Gene Med (2005) 0.88
Universal stress proteins are important for oxidative and acid stress resistance and growth of Listeria monocytogenes EGD-e in vitro and in vivo. PLoS One (2011) 0.87
Integrated functional visualization of eukaryotic genomes. BMC Bioinformatics (2006) 0.86
Identification and characterization of Di- and tripeptide transporter DtpT of Listeria monocytogenes EGD-e. Appl Environ Microbiol (2005) 0.86
Gram-positive pathogenic bacteria induce a common early response in human monocytes. BMC Microbiol (2010) 0.85
Listeria monocytogenes induced Rac1-dependent signal transduction in endothelial cells. Biochem Pharmacol (2006) 0.85
Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection. PLoS One (2012) 0.85
Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs. Toxins (Basel) (2013) 0.85
Anti-Listeria activities of Galleria mellonella hemolymph proteins. Appl Environ Microbiol (2011) 0.85
Chromosomal Locations of mcr-1 and bla CTX-M-15 in Fluoroquinolone-Resistant Escherichia coli ST410. Emerg Infect Dis (2016) 0.85
Novel bacterial artificial chromosome vector pUvBBAC for use in studies of the functional genomics of Listeria spp. Appl Environ Microbiol (2008) 0.84
Tailoring host immune responses to Listeria by manipulation of virulence genes -- the interface between innate and acquired immunity. FEMS Immunol Med Microbiol (2003) 0.84
sRNAdb: a small non-coding RNA database for gram-positive bacteria. BMC Genomics (2012) 0.84
Induction of suicidal erythrocyte death by listeriolysin from Listeria monocytogenes. Cell Physiol Biochem (2007) 0.84
Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant. Acta Paediatr (2008) 0.83
The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes. Innate Immun (2013) 0.83
Uropathogenic E. coli induce different immune response in testicular and peritoneal macrophages: implications for testicular immune privilege. PLoS One (2011) 0.83
Role of TLR- / NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection. Virulence (2011) 0.82
Highly specific and quick detection of Mycobacterium avium subsp. paratuberculosis in feces and gut tissue of cattle and humans by multiple real-time PCR assays. J Clin Microbiol (2011) 0.82
Structural and functional integrity of spermatozoa is compromised as a consequence of acute uropathogenic E. coli-associated epididymitis. Biol Reprod (2013) 0.82
Listeria monocytogenes ActA is a key player in evading autophagic recognition. Autophagy (2009) 0.82
Toll-like receptors and NOD-like receptors: domain architecture and cellular signalling. Adv Exp Med Biol (2009) 0.81
Listeria monocytogenes mediated CFTR transgene transfer to mammalian cells. J Gene Med (2002) 0.81
Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O. Int Immunol (2005) 0.81
Chronic prosthetic joint infection caused by Listeria monocytogenes. J Med Microbiol (2009) 0.81